Smartag International, Inc.

By collaborating with these two entities, new business models are expected for Company as the current businesses of the BMT and their micro finance houses will migrate towards the new sharia Fintech platforms whereby not only current domestic funds transfers, utility payments and small micro finance loans will continue but in a more efficient manner and with less expensive rates. Additionally, new and enlarged Fintech businesses of e-Commerce coupled with rural e-logistics distribution will be introduced for BMT members. Telkomsel has the wide reach into the rural interior where telecommunications connectivity is essential for operating the e-Wallet platform.

Wherever feasible the Company plans to add value with block chain traceability to increase the overall efficiency and reduce costs especially for B2B e-Logistics and e-Know Your Client or e-KYC technologies to recruit many more members for the e-Wallet. Our mission is to add value using our Fintech platform which includes new e-KYC and e-Logistics track and trace supply chain solutions. Our difference will be that many items found on the supply chain can be traced to the source of origin using block chain solutions. These solutions will not only safeguard the interests of the stakeholders within the supply chain route but will protect the needs of the customers. The customers need to know what is safe and genuine. The suppliers need the payment assurances at the other end of the supply chain.

The Company suffered recurring losses from operations and has an accumulated deficit of $3,560,458 at September 30, 2018.  Currently, we have not generated consistent revenues as of September 30, 2018, had a cash balance of $87,461. The Company is seeking various forms of financing.   To the extent additional funding is not achieved this will delay our business plans and the Company may not continue to operate. We do not have sufficient cash resources for the next 6 months, in order to meet our business goals, we will need to seek additional funding or enter into strategic partnerships.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. Our audits included performing procedures to assess the risks of material misstatement, whether due to error fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.

Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

Siew Hock Lau (age 62) - S.H. Lau, has been involved in several technological startups in the Silicon Valley, CA for the last 25 years, serving in various capacities from CEO, VP Sales & Marketing to VP of Business Development. He had been highly successful in launching several new high-tech products into the global marketplace. Regularly represents company as presenter and invited speaker at several international scientific conferences and workshops. Scored a successful exit with the last company, Xradia Inc, in 2013, when the company was acquired by Carl Zeiss, AG.   (Xradia Inc. manufactures ultra-high resolution X-ray CT scanners for research and industries).  He is currently the CEO of New Biotic, a clinical stage biotech startup specializing in therapeutics derived from human microbiome to treat neurological and psychiatric disorders.  Additionally, he is active in Angel investing, being a member of Shasta Angels. A business consultant, life coach and mentor, he also sits in the advisory board of Providence International, a nonprofit, devoted to developing job creating business partnerships to restore sustainable livelihood and scalable businesses to at risk people and families around the world. S.H. holds a B.Sc degree in Biochemistry, a teaching degree and an MBA.